Invited talks (Heidi Jacobs)
  • July 2020: “Transcutaneous vagus nerve stimulation increases locus coeruleus function and memory performance in older individuals”, Alzheimer’s Association International Conference, Amsterdam, The Netherlands (virtual)
  • July 2020: “Tracking the origin of tau spread in the brain”, Alzheimer’s Association International Conference, Amsterdam, The Netherlands (virtual)
  • July 2020: “Focus on the locus coeruleus: links with amyloid and tau pathology and cognitive decline”, MGH Multicultural Alzheimer’s Prevention Program Seminar
  • May 2020:”Elucidating the role of the locus coeruleus in Alzheimer’s disease from an aging perspective”, Cognitive Aging Conference, Atlanta, USA (cancelled due to COVID-19)
  • April 2020: “Linking brainstem and molecular changes in aging and AD”, MINC 2020 Symposium, Cologne, Germany (cancelled due to COVID-19)
  • March 2020: “Locus coeruleus integrity tracks with initial Alzheimer’s disease-related pathology and cognitive decline”, MGH Memory Disorders Unit & Movement Disorders Unit Conference, Boston, USA
  • January 2020: "Locus coeruleus integrity tracks with initial Alzheimer's disease related pathology and cognitive decline" at the Human Amyloid Imaging Conference, Miami, USA
  • December 2019: " Linking Norepinephrine - locus coeruleus measures to Alzheimer's disease pathology" at the second Locus Coeruleus Imaging Meeting, Magdeburg, Germany
  • May 2019: "Origin and spread of tau: associations with memory and aging" at the Charles River Association for Memory meeting at the  Boston University Center for Memory and Brain, Boston, USA.
  • April 2019: "Focus on the locus coeruleus" at the Dickerson lab meeting of the Athinoula A. Martinos Center for Biomedical Imaging, Boston, USA
  • July 2018: "Regional asymmetries in amyloid and tau go together: evidence for local interaction" at the Alzheimer's Association International Conference, Chicago, USA.
  • June 2018: :"Alzheimer's disease: Imaging Neuropathology in vivo" at the International Academy of Pathology and the Pathological Society of Great Britain and Ireland in Maastricht, the Netherlands.  
  • June 2018: " Tau propagation in preclinical Alzheimer's disease: Brainstem and cortical perspectives" at the Neuroscience Research Seminars at the Ludwig Maximilian University of Munich in Germany
  • February 2018: "Focus on the locus coeruleus with 7T MRI" at the first Locus Coeruleus Imaging meeting, Magdeburg, Germany
  • January 2018: "Coupling between amyloid and tau occurs at a younger age in APOE E4-carriers than non-carriers" at the Human Amyloid Imaging Conference, Miami, USA
  • August 2017: "Local diffusivity alterations predict local tau accumulation over time" at the Speech language and hearing sciences, Boston University, Boston, USA
  • June 2017: " Role of the locus coeruleus and the cerebellum in cognition: perspective from Alzheimer's disease" at the Spring Symposium of the Flemish Association for Neuropsychology, Leuven, Belgium
  • March 2017: " Hippocampal cingulum bundle integrity predicts downstream tau accumulation over time" at the lab meeting of the BaND-lab of the Athinoula A. Martinos Center for Biomedical Imaging, Boston, USA
  • March 2017: "Focus on the locus (coeruleus): link to memory dysfunction" at the Speakers series of the Neuroimaging and Neuropsychology group of the VA Hospital in Boston (USA)
  • July 2016: "The effect of tract-specific loss of white matter connectivity on cognitive decline in healthy older individuals depends upon posterior cingulate tau binding" at the Alzheimer's Association International Conference, Toronto, Canada
  • April 2016: "Neurodegeneration and compensation in the brains of patients with dementia: challenges and perspectives" at the Alzheimer Centre Limburg Symposium, Rijckholt, The Netherlands
  • January 2016: "The impact of amyloid and tau on the association between hippocampal volume and memory is subfield-specific" at the Human Amyloid Imaging Conference, Miami, USA
  • April 2015: “From neuropathology to mapping brain connectivity to modulating networks in Alzheimer’s disease” at the Psychopharmacology meeting of the Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands
  • December 2014: “Beyond medial temporal lobe dysfunction in Alzheimer’s disease” at the Fundamental Neuroscience Symposium, Maastricht, The Netherlands
  • November 2014: “ Mapping Alzheimer pathology with 7T MRI” at the University Fund Limburg meeting, Maastricht, The Netherlands
  • July 2014: “Using effective / functional and structural connectivity in early Alzheimer’s disease: the parietal lobe” at the 3rd Annual Retreat of the Institute for Neuroscience and Medicine, Research Centre Jülich, Jülich, Germany
  • November 2013: “Memory problems: when are they normal, when not?” at the 2. Kölner Demenz Symposium of the University Hospital of Cologne, Cologne, Germany
  • October 2013: “ New developments in the treatment of Alzheimer’s disease” at Open Dementia Meeting of the Dienstencentrum De Linde, Riemst, Belgium
  • September 2013: “Stability of resting-state networks as a predictor for cognitive decline” at the Erwin L. Hahn fMRI Workshop 2013, Essen, Germany
  • March 2013: “Cerebral-Cerebellar contributions to Alzheimer’s disease: evidence from structural and functional MRI” at the Neuroscience meeting of the School for Mental Health and Neuroscience, Maastricht University in Maastricht, The Netherlands.
  • October 2012:”Parietal matters in early Alzheimer’s disease: from connectivity to interventions” at the XII Annual Meeting of the International College of the International College of Geriatric Psychoneuropharmacology in Sevilla, Spain
  • May 2012: “The parietal lobe in early Alzheimer’s disease: an integrative approach” at the Research Day of the School of Mental Health and Neuroscience, Maastricht University in Maastricht, The Netherlands
  • April 2012: “De rol van de parietaalkwab in de vroege fase van de ziekte van Alzheimer: evidentie vanuit structurele en functionele MRI” [The role of the parietal lobe in early Alzheimer’s disease: evidence from structural and functional MRI] at the Voorjaarsmeeting of the Dutch Association for Psychiatry (NVvP) in Maastricht, The Netherlands
  • March 2012: “Het belang van de parietaalkwab in de vroege fase van de ziekte van Alzheimer: evidentie vanuit structurele en functionele MRI” [The relevance of the parietal lobe in early Alzheimer’s disease: evidence from structural and functional MRI] at the Winter meeting of Geriatrics and Gerontology in Oostende, Belgium
  • November 2011: ”Structural and functional parietal changes matter for the understanding and diagnosis of early Alzheimer’s disease” at the INSERM - Cyceron meeting in Caen, France
  • April 2011: “Neuroimaging: opportunities and new developments for dementia” at the PsychoGeriatric Meeting, in Maastricht, The Netherlands.
  • February 2011: “Parietal matters in early Alzheimer’s disease: evidence from structural and functional MRI” at the INM-3 Group meeting Forschungszentrum Julich, Germany
  • March 2009: “Neuroimaging of grey and white matter atrophy in cognitive ageing”  at the Research Day  of the School for Mental Health and Neuroscience in Maastricht, The Netherlands.
  • February 2008: “The parietal cortex in aging: atrophy patterns and connectivity” at the Marie Curie fellow meeting in Maastricht, The Netherlands.
  • February 2007: “Structural brain changes, cognitive aging and prodromes of Alzheimer’s disease: a neuroimaging approach” at the Marie Curie fellow meeting in Maastricht, The Netherlands.